ATE257387T1 - Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes - Google Patents
Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexesInfo
- Publication number
- ATE257387T1 ATE257387T1 AT95923374T AT95923374T ATE257387T1 AT E257387 T1 ATE257387 T1 AT E257387T1 AT 95923374 T AT95923374 T AT 95923374T AT 95923374 T AT95923374 T AT 95923374T AT E257387 T1 ATE257387 T1 AT E257387T1
- Authority
- AT
- Austria
- Prior art keywords
- disorders
- pct
- brain
- phospholipid
- abstract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Dispersion Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9407867A FR2721516B1 (fr) | 1994-06-27 | 1994-06-27 | Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation. |
PCT/FR1995/000771 WO1996000077A1 (fr) | 1994-06-27 | 1995-06-13 | Nouvelles utilisations d'un complexe a base de phospholipides cerebraux en therapeutique et dans l'alimentation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE257387T1 true ATE257387T1 (de) | 2004-01-15 |
Family
ID=9464681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95923374T ATE257387T1 (de) | 1994-06-27 | 1995-06-13 | Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes |
Country Status (10)
Country | Link |
---|---|
US (1) | US5853747A (de) |
EP (1) | EP0719152B2 (de) |
JP (1) | JPH09502458A (de) |
AT (1) | ATE257387T1 (de) |
AU (1) | AU701528B2 (de) |
CA (1) | CA2170243C (de) |
DE (1) | DE69532406T2 (de) |
ES (1) | ES2214503T3 (de) |
FR (1) | FR2721516B1 (de) |
WO (1) | WO1996000077A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2714574B1 (fr) * | 1993-12-31 | 1996-03-15 | Inst Rech Biolog Sa | Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants. |
FR2736265B1 (fr) * | 1995-07-07 | 1997-09-26 | Forgeot Marcel | Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives |
KR100190826B1 (ko) * | 1996-08-26 | 1999-06-01 | 강재헌 | 적혈구 용혈 억제용 약제학적 조성물 및 그의제조방법 |
FR2762993B1 (fr) * | 1997-05-06 | 1999-08-13 | Inst Rech Biolog Sa | Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique |
FR2788437B1 (fr) * | 1999-01-14 | 2006-08-11 | Inst Rech Biolog Sa | Nouvelle utilisation de phospholipides d'origine vegetale et animale en therapeutique nutritionnelle |
US20020192295A1 (en) * | 1999-01-14 | 2002-12-19 | Yves Ponroy | Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
DE19943198A1 (de) * | 1999-09-09 | 2001-03-15 | Meyer Lucas Gmbh & Co | Therapeutikum zur Behebung zentralnervöser Funktionsstörungen |
US7208180B2 (en) * | 2000-05-08 | 2007-04-24 | N.V. Nutricia | Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith |
PT1317272E (pt) * | 2000-05-25 | 2006-06-30 | Boehringer Ingelheim Int | Composicao para melhoramento da proteccao celular compreendendo um antioxidante lipofilo e um antioxidante hidrofilo |
AU2002213143A1 (en) * | 2000-10-12 | 2002-04-22 | Institute Of Materials Research And Engineering | Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells |
EP1339404A2 (de) * | 2000-10-31 | 2003-09-03 | Colgate-Palmolive Company | Zusammensetzung und verfahren |
US7048941B2 (en) | 2001-03-30 | 2006-05-23 | New World Enterprizes, Inc. | Chocolate composition as delivery system for nutrients and medications |
JP2004026803A (ja) * | 2002-03-29 | 2004-01-29 | Nof Corp | 神経細胞死予防剤 |
EP1632556A4 (de) * | 2003-06-09 | 2006-12-20 | Suntory Ltd | Neues desodorierungsverfahren für fettgeruch und dadurch erhaltene zusammensetzung |
US7199112B2 (en) * | 2005-08-10 | 2007-04-03 | William Llewellyn | Use of phospholipid arachidonic acids for increasing muscle mass in humans |
FI120720B (fi) * | 2006-06-16 | 2010-02-15 | Neurofood Ab Oy | Maitopohjaisia elintarvikkeita, jotka sisältävät keskushermoston lipidejä |
JP2008214338A (ja) * | 2007-02-08 | 2008-09-18 | Shiseido Co Ltd | 高次脳機能低下改善剤および遅延記憶低下改善剤 |
WO2012039472A1 (ja) * | 2010-09-24 | 2012-03-29 | 医療法人社団ブックス | 抗中枢神経系炎症剤 |
US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
NL2012795B1 (en) * | 2014-05-09 | 2016-02-24 | Sonac B V | Novel hydrolysate. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR5171M (de) * | 1966-02-11 | 1967-06-19 | ||
US4385053A (en) * | 1981-03-11 | 1983-05-24 | Barry Reisberg | Treatment for human memory impairment associated with aging |
JPS6229951A (ja) * | 1985-07-31 | 1987-02-07 | Showa Yakuhin Kako Kk | 脳髄粉末の製造法 |
IT1201151B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono |
IT1230141B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale. |
IT1260149B (it) * | 1992-04-17 | 1996-03-28 | Fidia Spa | Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali |
JPH0717855A (ja) * | 1992-09-02 | 1995-01-20 | Maruha Corp | 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品 |
CA2119000A1 (en) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation for use in smokers |
FR2714574B1 (fr) * | 1993-12-31 | 1996-03-15 | Inst Rech Biolog Sa | Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants. |
-
1994
- 1994-06-27 FR FR9407867A patent/FR2721516B1/fr not_active Expired - Fee Related
-
1995
- 1995-06-13 WO PCT/FR1995/000771 patent/WO1996000077A1/fr active IP Right Grant
- 1995-06-13 CA CA002170243A patent/CA2170243C/fr not_active Expired - Lifetime
- 1995-06-13 AT AT95923374T patent/ATE257387T1/de not_active IP Right Cessation
- 1995-06-13 DE DE69532406T patent/DE69532406T2/de not_active Expired - Fee Related
- 1995-06-13 JP JP8502855A patent/JPH09502458A/ja active Pending
- 1995-06-13 EP EP95923374A patent/EP0719152B2/de not_active Expired - Lifetime
- 1995-06-13 ES ES95923374T patent/ES2214503T3/es not_active Expired - Lifetime
- 1995-06-13 AU AU27953/95A patent/AU701528B2/en not_active Ceased
- 1995-06-13 US US08/617,806 patent/US5853747A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2795395A (en) | 1996-01-19 |
US5853747A (en) | 1998-12-29 |
EP0719152B1 (de) | 2004-01-07 |
CA2170243A1 (fr) | 1996-01-04 |
DE69532406D1 (de) | 2004-02-12 |
WO1996000077A1 (fr) | 1996-01-04 |
EP0719152B2 (de) | 2009-04-08 |
DE69532406T2 (de) | 2004-11-04 |
CA2170243C (fr) | 2005-05-24 |
JPH09502458A (ja) | 1997-03-11 |
ES2214503T3 (es) | 2004-09-16 |
AU701528B2 (en) | 1999-01-28 |
FR2721516A1 (fr) | 1995-12-29 |
FR2721516B1 (fr) | 1996-09-13 |
EP0719152A1 (de) | 1996-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE257387T1 (de) | Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes | |
HU9301978D0 (en) | Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin | |
AU6909091A (en) | Neurologic agents for nasal administration to the brain | |
DE69230046T2 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
SG52443A1 (en) | Methods and compositions for the treatment of disease with interferon while reducing sid effects | |
ZA951295B (en) | 6-substituted mycophenolic acid and derivatives | |
PL323798A1 (en) | Application of derivatives of vitamin d4 in treating skin diseases | |
SG50339A1 (en) | Fatty acid derivatives | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
MX9708800A (es) | Compuestos biciclicos aromaticos. | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
ATE296098T1 (de) | Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose | |
BR9814048A (pt) | "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia " | |
ZA874198B (en) | D-fenfluramine for use in the treatment of depression | |
MX9703810A (es) | Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro. | |
EP0147185A3 (de) | Therapeutische Verwendung von Cytidyl-Diphosphocholin für Steigerung von Neuronal-Acetylcholin | |
NZ299257A (en) | Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase | |
DE69510933T2 (de) | Amidderivate und ihre therapeutische anwendung | |
RU2038102C1 (ru) | Способ лечения вибрационной болезни | |
NZ268039A (en) | Use of efaroxan in treating parkinson's disease | |
NZ328915A (en) | use of sulbutiamine to treat psychomotor and psychointellectual disorders | |
FR2749509B1 (fr) | Procede de preparation d'une pate de soin epilatoire de maniere progressivement definitive avec effet de massage, desincrustante et astringente, hemostatique et apaisante | |
UA6490A (uk) | Пристрій для поверхневої рефлексоголкотерапії "сената" | |
粟坪华 et al. | Observation on 38 cases of drug-induced myospasm treated with massage over the acupoints |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |